drugset / Trial / NCT01000207

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

NCT01000207 ↗

Phase 2/3 Completed 123 enrolled Novartis Vaccines
RandomizedParallel-groupSingle-blindPrevention

Summary

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy children/adolescents based on European Medicines Agency's Committee for Medicinal Products for Human Use (EMEA/CHMP) criteria, and safety and tolerability.

Timeline

Start
2009-10
Primary completion
2009-12
Completion
2009-12

Indications